Adrian Miller

Psychological distress in three Australian communities living with environmental per- and polyfluoroalkyl substances contamination

Publisher: Elsevier BV

Date: 05-2023

DOI: 10.1016/J.SCITOTENV.2023.162503

Leading with local solutions to keep Yarrabah safe: A grounded theory study of an Aboriginal community- controlled health organisation’s response to COVID-19

Publisher: Research Square Platform LLC

Date: 15-04-2021

DOI: 10.21203/RS.3.RS-402607/V1

Abstract: Introduction Pandemics such as COVID-19 are a serious public health risk for Australian Aboriginal and Torres Strait Islander communities, yet primary healthcare systems are not well resourced to respond to such urgent events. At the start of the COVID-19 pandemic, a federal government advisory group recommended a rapid, tailored Indigenous response to prevent predicted high morbidity and mortality rates. This paper examines the efforts of one ACCHO, which in the absence of dedicated funding, pivoted its operations in response to COVID-19. Gurriny Yealamucka Health Service (Gurriny) is the only primary healthcare service in the discrete Indigenous community of Yarrabah, Far North Queensland. Methods The research was conducted at the request of the Chief Executive Officer of Gurriny. Grounded theory methods were used to s le and analyse transcripts of interviews with thirteen Gurriny staff and five others - Yarrabah and government leaders and community members, and 59 documents. Data were imported into NVIVO-12 and coded, with key concepts compared, organised into higher order constructs, then structured into a theoretical framework. Results Gurriny responded to COVID-19 by leading with local solutions to keep Yarrabah safe. Four key strategies were implemented: managing the health service operations, realigning services, educating and supporting community, and working across agencies. These strategies were enabled or hindered by five conditions: the governance and leadership capcity of Gurriny, relying on the health taskforce, locking the door, “copping it”, and (not) having resources. A year after the first case was experienced in Australia and on the eve of vaccine rollout to Indigenous communities, there have been no COVID-19 cases in Yarrabah. Discussion The success of the locally-led, holistic, comprehensive and culturally safe response of Gurriny suggests that such tailored place-based approaches to pandemics (and other health issues) are appropriate, but require dedicated resourcing. Key challenges related to fragmented and rapidly changing government processes, poorly coordinated communication and resource allocation channels, and bottlenecks in hierarchical funding approval processes. Conclusion The COVID-19 response in Yarrabah demonstrates the need for governance reform towards greater resourcing and support for local decision making.

Indigenous perspectives on the desired attributes of medical graduates practising in remote communities: A Northwest Queensland pilot study

Publisher: Wiley

Date: 04-2013

DOI: 10.1111/AJR.12018

Abstract: Providing an emphasis on Indigenous health in medical undergraduate education is seen as a high priority by Australian medical organisations. A regional North Queensland medical school asked local Indigenous people to list personal attributes they want to see in graduate doctors who choose to practise in their remote community. This 2011 pilot study used a participatory action research design, with 13 local Indigenous health professionals, elders and community members from Mount Isa participating as co-researchers in 'Yarning Circles' discussing desired medical graduate attributes. Medical school co-researchers inductively extracted themes from the discussions via a qualitative 'grounded theory' approach. Eight major subtopics were identified by the Mount Isa Indigenous community around desired skills, knowledge and attitudes for graduate doctors: provision of quality patient care culturally appropriate communication medical knowledge culturally appropriate knowledge knowing the local health system a positive personality a positive attitude to working with Indigenous peoples and a desire to engage with the Indigenous community. Effective communications with Indigenous patients and working in remote Indigenous communities requires doctors to have appropriate clinical skills, medical knowledge, knowledge about how local health systems operate, familiarity with significant Indigenous health issues such as child safety and alcohol management, and positive attitudes to working with, learning about and providing an advocacy role for Indigenous peoples. Findings have implications for enhancing the professional behaviours and engagement of James Cook University medical students in Indigenous communities while on rural placement and after graduation, and for Australian medical and health practitioners more broadly.

Australian Aboriginal and Torres Strait Islander communities and the development of pandemic influenza containment strategies: Community voices and community control

Publisher: Elsevier BV

Date: 12-2011

DOI: 10.1016/J.HEALTHPOL.2011.07.004

Abstract: To develop culturally appropriate and effective strategies to reduce the risk from pandemic influenza (H1N109) in rural and remote Australian Aboriginal and Torres Strait Islander communities. Participatory Action Research (PAR) approach that enabled communities and researchers to work together to develop understanding and take action to reduce risk. The H1N109 pandemic raised deep concerns and serious issues in all of the Aboriginal and Torres Strait Islander communities involved in this project. The participants expressed distrust and scepticism in relation to current Australian health policies on containment and told the researchers that specific plans for Aboriginal and Torres Strait Islander peoples were needed. Respondents indicated that policies and plans had been developed without respectful engagement with communities. The strong and recurring themes that emerged from the PAR cycles were: the importance of family ways of life and realities of living in response to influenza and key messages to government and health services to focus on communication, understanding and respect. The essential work of reducing risk of pandemic influenza with Aboriginal and Torres Strait Islander communities is not straightforward, but this project has highlighted a number of useful pathways to continue to journey along with communities. A number of strategies to reduce the spread of pandemic influenza in Aboriginal and Torres Strait Islander communities were identified. These strategies would make a good starting point for conversations with communities and health services. In Aboriginal and Torres Strait Islander communities the environment, community structures and traditions vary. Respectful engagement with communities is needed to develop effective policy.

Strongyloides stercoralis: Systematic Review of Barriers to Controlling Strongyloidiasis for Australian Indigenous Communities

Publisher: Public Library of Science (PLoS)

Date: 25-09-2014

DOI: 10.1371/JOURNAL.PNTD.0003141

Molecular basis for universal HLA-A^∗0201-restricted CD8⁺ T-cell immunity against influenza viruses

Publisher: Proceedings of the National Academy of Sciences

Date: 31-03-2016

DOI: 10.1073/PNAS.1603106113

Abstract: Influenza is a rapidly spreading acute respiratory infection that causes profound morbidity and mortality. Established CD8 + T-lymphocyte (CTL) immunity directed at conserved viral regions provides protection against distinct influenza A viruses (IAVs). In this study, we show that public T-cell receptors (TCRs) specific for the most prominent human CTL epitope (M1 58–66 restricted by HLA-A*0201) are capable of recognizing sporadically emerging variant IAVs. We also identify the structural mechanisms that enable promiscuous TCR recognition in this context. Our analysis suggests that preexisting cross-reactive TCRs may limit the spread of newly emerging pandemic IAVs.

A Community-Directed Integrated Strongyloides Control Program in Queensland, Australia

Publisher: MDPI AG

Date: 04-05-2018

DOI: 10.3390/TROPICALMED3020048

CD8+ T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph

Publisher: Springer Science and Business Media LLC

Date: 18-05-2021

DOI: 10.1038/S41467-021-23212-X

Abstract: Indigenous people worldwide are at high risk of developing severe influenza disease. HLA-A*24:02 allele, highly prevalent in Indigenous populations, is associated with influenza-induced mortality, although the basis for this association is unclear. Here, we define CD8 + T-cell immune landscapes against influenza A (IAV) and B (IBV) viruses in HLA-A*24:02-expressing Indigenous and non-Indigenous in iduals, human tissues, influenza-infected patients and HLA-A*24:02-transgenic mice. We identify immunodominant protective CD8 + T-cell epitopes, one towards IAV and six towards IBV, with A24/PB2 550–558 -specific CD8 + T cells being cross-reactive between IAV and IBV. Memory CD8 + T cells towards these specificities are present in blood (CD27 + CD45RA − phenotype) and tissues (CD103 + CD69 + phenotype) of healthy in iduals, and effector CD27 − CD45RA − PD-1 + CD38 + CD8 + T cells in IAV/IBV patients. Our data show influenza-specific CD8 + T-cell responses in Indigenous Australians, and advocate for T-cell-mediated vaccines that target and boost the breadth of IAV/IBV-specific CD8 + T cells to protect high-risk HLA-A*24:02-expressing Indigenous and non-Indigenous populations from severe influenza disease.

Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians

Publisher: Proceedings of the National Academy of Sciences

Date: 04-10-2021

DOI: 10.1073/PNAS.2109388118

Abstract: Indigenous populations worldwide are highly susceptible to influenza virus infections. Vaccination with inactivated virus is highly recommended to protect Indigenous populations, including Indigenous Australians. There is no study to date that assessed immune responses induced by the inactivated seasonal influenza vaccine in the Indigenous population. Vaccine recommendations are thus based on data generated for non-Indigenous populations and might not be representative for Indigenous people. We found robust antibody responses to influenza vaccination induced in Indigenous Australians, with activation profiles of cT FH 1 cells at the acute response strongly correlating with total change of antibody vaccine titers induced by vaccination. Our work strongly supports the recommendation of influenza vaccination to protect Indigenous populations from severe seasonal influenza virus infections and subsequent complications.

HLA-A^∗11:01-restricted CD8⁺ T cell immunity against influenza A and influenza B viruses in Indigenous and non-Indigenous people

Publisher: Public Library of Science (PLoS)

Date: 07-03-2022

DOI: 10.1371/JOURNAL.PPAT.1010337

Abstract: HLA-A*11:01 is one of the most prevalent human leukocyte antigens (HLAs), especially in East Asian and Oceanian populations. It is also highly expressed in Indigenous people who are at high risk of severe influenza disease. As CD8 + T cells can provide broadly cross-reactive immunity to distinct influenza strains and subtypes, including influenza A, B and C viruses, understanding CD8 + T cell immunity to influenza viruses across prominent HLA types is needed to rationally design a universal influenza vaccine and generate protective immunity especially for high-risk populations. As only a handful of HLA-A*11:01-restricted CD8 + T cell epitopes have been described for influenza A viruses (IAVs) and epitopes for influenza B viruses (IBVs) were still unknown, we embarked on an epitope discovery study to define a CD8 + T cell landscape for HLA-A*11:01-expressing Indigenous and non-Indigenous Australian people. Using mass-spectrometry, we identified IAV- and IBV-derived peptides presented by HLA-A*11:01 during infection. 79 IAV and 57 IBV peptides were subsequently screened for immunogenicity in vitro with peripheral blood mononuclear cells from HLA-A*11:01-expressing Indigenous and non-Indigenous Australian donors. CD8 + T cell immunogenicity screening revealed two immunogenic IAV epitopes (A11/PB2 320-331 and A11/PB2 323-331 ) and the first HLA-A*11:01-restricted IBV epitopes (A11/M 41-49 , A11/NS1 186-195 and A11/NP 511-520 ). The immunogenic IAV- and IBV-derived peptides were % conserved among their respective influenza viruses. Identification of novel immunogenic HLA-A*11:01-restricted CD8 + T cell epitopes has implications for understanding how CD8 + T cell immunity is generated towards IAVs and IBVs. These findings can inform the development of rationally designed, broadly cross-reactive influenza vaccines to ensure protection from severe influenza disease in HLA-A*11:01-expressing in iduals.

Argument for Inclusion of Strongyloidiasis in the Australian National Notifiable Disease List

Publisher: MDPI AG

Date: 05-06-2018

DOI: 10.3390/TROPICALMED3020061

Epidemiological trends in notified influenza cases in Australia’s Northern Territory, 2007‐2016

Publisher: Wiley

Date: 23-05-2020

DOI: 10.1111/IRV.12757

Broad spectrum SARS-CoV-2-specific immunity in hospitalized First Nations peoples recovering from COVID-19

Publisher: Wiley

Date: 19-09-2023

DOI: 10.1111/IMCB.12691

The association between fear of falling and orthostatic hypotension in older adults

Publisher: Springer Science and Business Media LLC

Date: 11-05-2020

DOI: 10.1007/S40520-020-01584-2

Deaths in young people after contact with the youth justice system: a retrospective data linkage study

Publisher: Swansea University

Date: 05-09-2018

DOI: 10.23889/IJPDS.V3I4.899

Abstract: IntroductionYoung people who have contact with the youth justice system are distinguished by a high prevalence of complex, co-occurring health problems, including known risk factors for preventable mortality. However, almost nothing is known about health outcomes for these young people after separation from the youth justice system. Objectives and ApproachWe aimed to examine the incidence, timing, causes and risk factors for death in justice-involved young people. We linked youth justice records in Queensland, Australia 1993-2016 (N=48,963) with adult correctional records and the National Death Index. We split the cohort into three subgroups: those who had ever been in detention (n=7,643), those supervised in the community but never detained (n=12,953), and those charged with an offence but never convicted (n=28,367). We calculated all-cause and cause-specific crude mortality rates (CMRs), and indirectly standardised mortality ratios (SMRs). We used Cox regression to identify static and time-varying risk factors for death. ResultsDuring a median of 13.6 years of follow-up there were 1,452 deaths (3.0%). The all-cause CMR was 2.2 (95%CI 2.1-2.3) per 1000 person-years, and the all-cause SMR was 3.1 (95%CI 3.0-3.3). The leading external causes of death were suicide (32% of all deaths), transport accidents (16%), accidental drug-related causes (13%), and violence (3%). In adjusted analyses, independent risk factors for all-cause mortality included being male (HR=1.4, 95%CI 1.2-1.6) and older ( =15 vs. vs. charge only HR=1.6, 95%CI 1.2-2.0) and subsequent incarceration as an adult (HR=1.8, 95%CI 1.4-2.4). Conclusion/ImplicationsYoung people who have contact with the youth justice system are at markedly increased risk of preventable death, after separation from that system. Efforts to improve long-term health outcomes for justice-involved youth have the potential to reduce preventable deaths in these highly vulnerable young people.

NS1′ of Flaviviruses in the Japanese Encephalitis Virus Serogroup Is a Product of Ribosomal Frameshifting and Plays a Role in Viral Neuroinvasiveness

Publisher: American Society for Microbiology

Date: 02-2010

DOI: 10.1128/JVI.01979-09

Abstract: Flavivirus NS1 is a nonstructural protein involved in virus replication and regulation of the innate immune response. Interestingly, a larger NS1-related protein, NS1′, is often detected during infection with the members of the Japanese encephalitis virus serogroup of flaviviruses. However, how NS1′ is made and what role it performs in the viral life cycle have not been determined. Here we provide experimental evidence that NS1′ is the product of a −1 ribosomal frameshift event that occurs at a conserved slippery heptanucleotide motif located near the beginning of the NS2A gene and is stimulated by a downstream RNA pseudoknot structure. Using site-directed mutagenesis of these sequence elements in an infectious clone of the Kunjin subtype of West Nile virus, we demonstrate that NS1′ plays a role in viral neuroinvasiveness.

Strongyloidiasis: a case for notification in Australia?

Publisher: AMPCo

Date: 06-2015

DOI: 10.5694/MJA15.00112

Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities

Publisher: Springer Science and Business Media LLC

Date: 29-05-2023

DOI: 10.1038/S41590-023-01508-Y

Abstract: High-risk groups, including Indigenous people, are at risk of severe COVID-19. Here we found that Australian First Nations peoples elicit effective immune responses to COVID-19 BNT162b2 vaccination, including neutralizing antibodies, receptor-binding domain (RBD) antibodies, SARS-CoV-2 spike-specific B cells, and CD4 + and CD8 + T cells. In First Nations participants, RBD IgG antibody titers were correlated with body mass index and negatively correlated with age. Reduced RBD antibodies, spike-specific B cells and follicular helper T cells were found in vaccinated participants with chronic conditions (diabetes, renal disease) and were strongly associated with altered glycosylation of IgG and increased interleukin-18 levels in the plasma. These immune perturbations were also found in non-Indigenous people with comorbidities, indicating that they were related to comorbidities rather than ethnicity. However, our study is of a great importance to First Nations peoples who have disproportionate rates of chronic comorbidities and provides evidence of robust immune responses after COVID-19 vaccination in Indigenous people.

Identifying Target Markets: Indigenous Community Directed Capacity Building – Final Report

Publisher: Commissioned by the Equity and Diversity Office, Southern Cross University

Date: 2013

DOI: 10.13140/RG.2.2.33709.90087

Challenging immunodominance of influenza-specific CD8⁺ T cell responses restricted by the risk-associated HLA-A*68:01 allomorph

Publisher: Springer Science and Business Media LLC

Date: 06-12-2019

DOI: 10.1038/S41467-019-13346-4

Abstract: Although influenza viruses lead to severe illness in high-risk populations, host genetic factors associated with severe disease are largely unknown. As the HLA-A*68:01 allele can be linked to severe pandemic 2009-H1N1 disease, we investigate a potential impairment of HLA-A*68:01-restricted CD8 + T cells to mount robust responses. We elucidate the HLA-A*68:01 + CD8 + T cell response directed toward an extended influenza-derived nucleoprotein (NP) peptide and show that only ~35% in iduals have immunodominant A68/NP 145 + CD8 + T cell responses. Dissecting A68/NP 145 + CD8 + T cells in low vs. medium/high responders reveals that high responding donors have A68/NP 145 + CD8 + memory T cells with clonally expanded TCRαβs, while low-responders display A68/NP 145 + CD8 + T cells with predominantly naïve phenotypes and non-expanded TCRαβs. Single-cell index sorting and TCRαβ analyses link expansion of A68/NP 145 + CD8 + T cells to their memory potential. Our study demonstrates the immunodominance potential of influenza-specific CD8 + T cells presented by a risk HLA-A*68:01 molecule and advocates for priming CD8 + T cell compartments in HLA-A*68:01-expressing in iduals for establishment of pre-existing protective memory T cell pools.

Protocol for a feasibility study of an Indigenous Medication Review Service (IMeRSe) in Australia

Publisher: BMJ

Date: 11-2018

DOI: 10.1136/BMJOPEN-2018-026462

Abstract: The age-adjusted rate of potentially preventable hospitalisations for Aboriginal and Torres Strait Islander people is almost five times the rate of other Australians. Quality use of medicines has an important role in alleviating these differences. This requires strengthening existing medication reviewing services through collaboration between community pharmacists and health workers, and ensuring services are culturally appropriate. This Indigenous Medication Review Service (IMeRSe) study aims to develop and evaluate the feasibility of a culturally appropriate medication management service delivered by community pharmacists in collaboration with Aboriginal health workers. This study will be conducted in nine Aboriginal health services (AHSs) and their associated community pharmacies in three Australian states over 12 months. Community pharmacists will be trained to improve their awareness and understanding of Indigenous health and cultural issues, to communicate the quality use of medicines effectively, and to strengthen interprofessional relationships with AHSs and their staff. Sixty consumers (with a chronic condition regnant/within 2 years post partum and at risk of medication-related problems (MRPs) per site will be recruited, with data collection at baseline and 6 months. The primary outcome is the difference in cumulative incidence of serious MRPs in the 6 months after IMeRSe introduction compared with the 6 months prior. Secondary outcomes include potentially preventable medication-related hospitalisations, medication adherence, total MRPs, psychological and social empowerment, beliefs about medication, treatment satisfaction and health expenditure. The protocol received approval from Griffith University (HREC/2018/251), Queensland Health Metro South (HREC/18/QPAH/109), Aboriginal Health and Medical Research Council of New South Wales (1381/18), Far North Queensland (HREC/18/QCH/86-1256) and the Central Australian HREC (CA-18-3090). Dissemination to Indigenous people and communities will be a priority. Results will be available on the Australian Sixth Community Pharmacy Agreement website and published in peer-reviewed journals. ACTRN12618000188235 Pre-results.

Study Protocol - Alcohol Management Plans (AMPs) in remote indigenous communities in Queensland: their impacts on injury, violence, health and social indicators and their cost-effectiveness

Publisher: Springer Science and Business Media LLC

Date: 09-01-2014

DOI: 10.1186/1471-2458-14-15

T Cell Epitope Discovery in the Context of Distinct and Unique Indigenous HLA Profiles

Publisher: Frontiers Media SA

Date: 06-05-2022

DOI: 10.3389/FIMMU.2022.812393

Abstract: CD8 + T cells are a pivotal part of the immune response to viruses, playing a key role in disease outcome and providing long-lasting immunity to conserved pathogen epitopes. Understanding CD8 + T cell immunity in humans is complex due to CD8 + T cell restriction by highly polymorphic Human Leukocyte Antigen (HLA) proteins, requiring T cell epitopes to be defined for different HLA allotypes across different ethnicities. Here we evaluate strategies that have been developed to facilitate epitope identification and study immunogenic T cell responses. We describe an immunopeptidomics approach to sequence HLA-bound peptides presented on virus-infected cells by liquid chromatography with tandem mass spectrometry (LC-MS/MS). Using antigen presenting cell lines that stably express the HLA alleles characteristic of Indigenous Australians, this approach has been successfully used to comprehensively identify influenza-specific CD8 + T cell epitopes restricted by HLA allotypes predominant in Indigenous Australians, including HLA-A*24:02 and HLA-A*11:01. This is an essential step in ensuring high vaccine coverage and efficacy in Indigenous populations globally, known to be at high risk from influenza disease and other respiratory infections.

Giving it a burl: towards the integration of genetics, isotope chemistry, and osteoarchaeology in Cape York, Tropical North Queensland, Australia

Publisher: Informa UK Limited

Date: 08-08-2019

DOI: 10.1080/00438243.2019.1686418

Letter to the Editor in response to the article by Borg et al

Publisher: Elsevier BV

Date: 06-2019

DOI: 10.1016/J.VACCINE.2019.05.021

Towards identification of immune and genetic correlates of severe influenza disease in Indigenous Australians

Publisher: Wiley

Date: 17-11-2015

DOI: 10.1038/ICB.2015.93

Identifying and understanding the drivers of high water consumption in remote Australian Aboriginal and Torres Strait Island communities

Publisher: Elsevier BV

Date: 2016

DOI: 10.1016/J.JCLEPRO.2017.11.168

Determinants of Attraction, Retention and Completion for Aboriginal and Torres Strait Islander Higher Degree Research Students: A Systematic Review to Inform Future Research Directions

Publisher: Springer Science and Business Media LLC

Date: 21-05-2018

DOI: 10.1007/S11162-018-9511-5

Large ovarian cystadenofibroma causing large bowel obstruction in a patient with Klippel–Feil syndrome—A case report

Publisher: Elsevier BV

Date: 2016

DOI: 10.1016/J.IJSCR.2015.12.046

Policy Implications for Controlling Communicable Diseases in Indigenous Communities: Case of Strongyloidiasis in Australia

Publisher: Aboriginal Policy Studies

Date: 03-04-2018

DOI: 10.5663/APS.V7I1.28898

Abstract: The objective of this paper is to document the knowledge and experiences of healthcare professionals and researchers in Australia about the barriers to controlling Strongyloides stercoralis in Australian Indigenous communities. Qualitative research methods were used to conduct in-depth semi-structured interviews, which were digitally recorded, transcribed, and participant-checked. Data were thematically analysed to identify significant themes. Five major themes were identified:1) Barriers to health/treatment ) Access to healthcare ) Policy ) Learning opportunity and5) Ideas for intervention.The findings suggest that Australian Indigenous communities will continue to suffer increased morbidity and mortality due to a lack of control or prevention of Strongyloides stercoralis. Issues such as institutional racism, improvements to health promotion, education, socioeconomic determinants, and health care system policy and procedures need to be addressed. This study identifies several direct implications for Indigenous health:The need for increased knowledge and understanding of the risks to health for Indigenous community members The need for prevention policy development for neglected tropical diseases in Indigenous communities The need for increased knowledge and understanding of the treatment, diagnosis, and healthcare access concerning Strongyloides stercoralis for health professionals and policymakers who work within Indigenous health The need to raise awareness of systematic institutional racism in the control and prevention of neglected tropical diseases in Indigenous communities andThe need for a health promotion framework that can provide the basis for multiple-level interventions to control and prevent Strongyloides in Indigenous communities.

Central Queensland University

Location: Australia

View Organisation

Macquarie University

Location: Australia

View Organisation

Charles Darwin University

Location: Australia

View Organisation

James Cook University

Location: Australia

View Organisation

Griffith University

Location: Australia

View Organisation

Southern Cross University

Location: Australia

View Organisation

Securing The Essential: Assisting Indigenous Communities And Their Service Providers To Sustainably Manage Water And Energy Supply.

Start Date: 2014

End Date: 2023

Funder: Australian Research Council

The Australian Centre For The Control And Elimination Of Neglected Tropical Diseases (ACE-NTDs)

Start Date: 2019

End Date: 2023

Funder: National Health and Medical Research Council

Harmful Mutations Specific To Indigenous Populations

Start Date: 2018

End Date: 2020

Funder: Australian Research Council

Generation Of Protective Immunity Against Severe Influenza In Indigenous Australians

Start Date: 2017

End Date: 2012

Funder: National Health and Medical Research Council

Australian Partnership For Preparedness Research On Infectious Disease Emergencies (APPRISE)

Start Date: 2016

End Date: 2012

Funder: National Health and Medical Research Council

Characterising The Deleterious Mutational Load In Aboriginal Australians.

Start Date: 2016

End Date: 2012

Funder: Australian Research Council

From Subarctic Ontario, Canada, To The Subtropics Of New South Wales, Australia: The Potential Use Of Strategic Environmental Assessment To Protect The Core Elements Of Indigenous Culture

Start Date: 2016

End Date: 2012

Funder: Social Sciences and Humanities Research Council of Canada

Establishing The Provenance Of Torres Strait Islander Remains: Genetics, Craniometrics And Isotopes

Start Date: 2014

End Date: 2017

Funder: Australian Research Council

Alcohol Management Plans (AMPs) In Remote Indigenous Communities.

Start Date: 2013

End Date: 2015

Funder: National Health and Medical Research Council

Developing A Universal Flu Vaccine For The Indigenous Population

Start Date: 2013

End Date: 2012

Funder: National Health and Medical Research Council

A Qualitative Study Of Barriers To Effective Infectious And Parasitic Disease Interventions In Aboriginal Communities

Start Date: 2008

End Date: 2012

Funder: Australian Research Council

Deaths In Young People Involved In The Youth Justice System: Towards Evidence-based Prevention

Start Date: 2016

End Date: 2020

Funder: National Health and Medical Research Council

A Partnership Approach To Sustainably Eliminating Chronic Hepatitis B In The Northern Territory: Hep B PAST

Start Date: 2018

End Date: 2021

Funder: National Health and Medical Research Council

Pandemic Influenza Containment Strategies In In Aboriginal Communities: What Is Acceptable And Feasible?

Start Date: 2010

End Date: 2012

Funder: National Health and Medical Research Council

Feasible Containment Strategies For Swine Influenza H1N1 In Rural And Remote Indigenous Communities

Start Date: 2009

End Date: 2010

Funder: National Health and Medical Research Council

Linkage Projects - Grant ID: LP160100594

Start Date: 08-2016

End Date: 08-2022

Amount: $178,464.00

Funder: Australian Research Council

Discovery Projects - Grant ID: DP180100089

Start Date: 02-2018

End Date: 12-2023

Amount: $401,573.00

Funder: Australian Research Council

Linkage Projects - Grant ID: LP140100118

Start Date: 04-2015

End Date: 06-2018

Amount: $241,366.00

Funder: Australian Research Council

Linkage Projects - Grant ID: LP140100387

Start Date: 06-2015

End Date: 12-2018

Amount: $740,880.00

Funder: Australian Research Council

Linkage Projects - Grant ID: LP210301323

Start Date: 07-2023

End Date: 01-2026

Amount: $448,440.00

Funder: Australian Research Council

Discovery Indigenous Researchers Development - Grant ID: DI0989521

Start Date: 04-2009

End Date: 12-2015

Amount: $150,000.00

Funder: Australian Research Council